At CTS, we understand the impact converting to the Ortho viral marker platform has on your operations. As we get closer to our implementation date of January 11, 2021 we are committed to providing you information as it becomes available.
Package inserts for the new assays are now available. You can review them on the Communications page by clicking this link: Communications,
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...